THE DEPLOYMENT OF GENOMIC MEDICINE: THE ROLE OF PATIENT AUTONOMY IN THE RE-USE OF GENETIC DATA FOR RESEARCH PURPOSES

Authors

  • Lisa FERIOL UMR 1295 CERPOP Inserm, Université de Toulouse III - Paul Sabatier.
  • Emmanuelle RIAL-SEBBAG UMR 1295 CERPOP Inserm, Université de Toulouse III - Paul Sabatier.

Keywords:

genetic data sharing, research, autonomy, consent, opt-out

Abstract

Genetic research today is largely based on the reuse of data from care for the benefit of research. This evolution of practices, which involves an increasingly marked communication between care and research, questions the place given to the patient seen as a potential participant in research. In order to promote the circulation of genetic data generated and to allow their reuse for the benefit of different research, the French legislator reaffirmed the use of the opt-out mechanism (“non-opposition”) in the last bioethics law of the 2 August 2021. If the reasons that led the legislator to make this shift from the concept of consent to the opt-out mechanism are legitimate, the conditions of implementation of this mechanism seem to need to be questioned in order to ensure the effectivity of the balance sought by the legislator between preserving the autonomy of the individual with regard to the sharing of his/her genetic data and encouraging the development of medical knowledge; one should not be to the detriment of the other.

Published

2023-09-08

How to Cite

Lisa FERIOL, & Emmanuelle RIAL-SEBBAG. (2023). THE DEPLOYMENT OF GENOMIC MEDICINE: THE ROLE OF PATIENT AUTONOMY IN THE RE-USE OF GENETIC DATA FOR RESEARCH PURPOSES. Journal International De bioéthique Et d’éthique Des Sciences, 34(2), 89. Retrieved from https://journaleska.com/index.php/jidb/article/view/9020

Issue

Section

Articles